Medicare ACO Cost Incentives For Part B-To-D Rx Shifts Worry Stakeholders
Executive Summary
CMS should look for ways to ensure that financial incentives for Medicare accountable care organizations do not promote inappropriate shifts in prescribing from the Part B benefit to Part D, biotech and clinician groups urge in comments filed with the agency June 6.
You may also be interested in...
CMS Interested In Part D Plan Collaboration With Medicare ACOs
In a draft version of its annual instructions to Part D plans, CMS says it is seeking feedback from Part D sponsors and other stakeholders on “possible strategies for achieving better coordination” between stand-alone Medicare Part D plans and accountable care organizations to improve pharmacy care.
Final Medicare ACO Rule Rejects Pharma Industry Requests For Rx Access Protections
Final rule on Medicare accountable care organizations created under the Affordable Care Act is released Oct. 20.
CMS Innovation Center Builds Infrastructure
Five divisions include a "seamless" care group to oversee accountable care organizations and similar delivery models.